date:Sep 21, 2012
misleadingly implied that breastfeeding should stop at six months, and questioned if the ads sufficiently differentiated between infant formula and follow-on formula.
The ASA concluded that these points were not misleading, but ordered Pfizer to make necessary adjustment to the ads, stating: The ads must not appear again in their current form.
Pfizer disappointed
Pfizer has voiced its disappointment in the ruling, stating that it takes compliance with advertising laws very seriously.
SMA Nut